Recent advances and challenges in antibacterial drug development
This special issue of ADMET and DMPK is guest-edited by Lynn Silver, LL Silver Consulting. It will critically address challenges in antibacterial drug development, translational hurdles, innovative approaches and advances in preclinical pipelines. The topics of the special issue include but are not limited to:
- Antibacterial drug resistance,
- Novel targets,
- Multi-targeting agents,
- Repurposed drugs,
- Derivatives of existing classes,
- Potentiators (e.g. efflux pump inhibitors),
- Antibodies, vaccines and immune-modulators.
The special issue is planned for January 2022. The deadline for manuscript submission is November 15, 2021.